Company Filing History:
Years Active: 2006
Title: Frederic Pilotaz: Innovator in Ophthalmic Pharmaceutical Composition
Introduction
Frederic Pilotaz is a notable inventor based in Chamalieres, France. He has made significant contributions to the field of ophthalmology through his innovative work in pharmaceutical compositions. His expertise and dedication to improving eye care have led to the development of a unique formulation aimed at preventing and treating eye infections.
Latest Patents
Frederic Pilotaz holds a patent for a pharmaceutical composition based on macrolides for topical application in ophthalmology. This invention focuses on a composition designed for local application to prevent and treat eye infections. Specifically, it is formulated as an eye lotion that can be distributed by drops. The composition includes an antibiotic of the macrolide class, such as azithromycin, dissolved in an oily vehicle. This vehicle consists primarily of medium-chain triglycerides, where the alcohol functions of glycerol are entirely esterified by carboxylic acids derived from saturated hydrocarbons. The fatty acids used in this formulation typically range from 5 to 12 carbon atoms, with a preference for linear-chain fatty acids like caprylic acid or capric acid. The preparation of this composition is conducted at a temperature not exceeding 70°C.
Career Highlights
Frederic Pilotaz has established himself as a key figure in the pharmaceutical industry, particularly in the development of innovative treatments for eye conditions. His work at Laboratories Thea has been instrumental in advancing ophthalmic care. His dedication to research and development has resulted in a patent that addresses a critical need in the medical field.
Collaborations
Frederic collaborates with Jacques Luyckx, contributing to the advancement of pharmaceutical innovations. Their partnership exemplifies the importance of teamwork in achieving breakthroughs in medical science.
Conclusion
Frederic Pilotaz's contributions to ophthalmology through his patented pharmaceutical composition highlight his commitment to improving eye health. His innovative approach and collaboration with industry professionals continue to pave the way for advancements in the field.